LORI M GUYTON
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- HERRIN, IL
- NPI
- 1295725752
- Received
- $1,139,241 in 2,602 records, 2019 to 2025 ($1,138,751 general, $490 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 307 | $151,028 |
| 2024 | General payment | 293 | $100,151 |
| 2023 | General payment | 322 | $130,256 |
| 2022 | General payment | 377 | $188,319 |
| 2021 | General payment | 343 | $121,563 |
| 2020 | General payment | 396 | $147,349 |
| 2020 | Research payment | 1 | $490 |
| 2019 | General payment | 563 | $300,080 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 351 | $706,705 |
| Travel and Lodging | 511 | $208,995 |
| Consulting Fee | 76 | $137,994 |
| Food and Beverage | 1,616 | $41,859 |
| Compensation for serving as faculty or as a speaker for a medical education program | 25 | $30,332 |
| Honoraria | 10 | $10,995 |
| Education | 12 | $1,868 |
| Research payment | 1 | $490 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-19 | Otsuka America Pharmaceutical, Inc. | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | Otsuka America Pharmaceutical, Inc. | $13 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-16 | Celgene Corporation | $29 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-12-16 | TG Therapeutics, Inc. | $6 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-12-15 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-12-05 | Otsuka America Pharmaceutical, Inc. | $3,784 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-05 | ARGENX US, INC. | $3,500 | Consulting Fee | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-12-04 | Otsuka America Pharmaceutical, Inc. | $1,883 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | Grifols USA, LLC | $17 | Food and Beverage | In-kind items and services | Gamunex-C Biological, Immunology and Neurology | 2025 | |
| 2025-12-04 | TG Therapeutics, Inc. | $6 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-12-03 | Otsuka America Pharmaceutical, Inc. | $137 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-02 | Otsuka America Pharmaceutical, Inc. | $168 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-12-02 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-26 | Eisai Inc. | $1,000 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-25 | Otsuka America Pharmaceutical, Inc. | $29 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-22 | ARGENX US, INC. | $339 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-22 | ARGENX US, INC. | $270 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-22 | ARGENX US, INC. | $50 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-22 | ARGENX US, INC. | $38 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-22 | ARGENX US, INC. | $25 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-21 | ARGENX US, INC. | $87 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-21 | ARGENX US, INC. | $65 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-20 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-20 | TG Therapeutics, Inc. | $10 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-11-18 | E.R. Squibb & Sons, L.L.C. | $123 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-17 | Eisai Inc. | $480 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-17 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-11-14 | Eisai Inc. | $511 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $400 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $400 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $117 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $43 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-13 | Eisai Inc. | $12 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-12 | Eisai Inc. | $2,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-12 | Eisai Inc. | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-12 | Eisai Inc. | $23 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-12 | Eisai Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-12 | Eisai Inc. | $19 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-11-11 | E.R. Squibb & Sons, L.L.C. | $3,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-11 | E.R. Squibb & Sons, L.L.C. | $2,640 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-11 | E.R. Squibb & Sons, L.L.C. | $2,640 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-11 | Eisai Inc. | $517 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-10 | TG Therapeutics, Inc. | $28 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-11-06 | ARGENX US, INC. | $3,500 | Consulting Fee | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-04 | Celgene Corporation | $26 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-04 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-10-30 | E.R. Squibb & Sons, L.L.C. | $1,080 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-29 | E.R. Squibb & Sons, L.L.C. | $1,265 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-29 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-28 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-27 | Eisai Inc. | $621 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-27 | JAZZ PHARMACEUTICALS INC. | $31 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-23 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-23 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | E.R. Squibb & Sons, L.L.C. | $66 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-21 | UCB, Inc. | $23 | Food and Beverage | In-kind items and services | Rystiggo Drug, Neurology | 2025 | |
| 2025-10-20 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-15 | ARGENX US, INC. | $378 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-15 | ARGENX US, INC. | $326 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-15 | ARGENX US, INC. | $13 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-14 | ARGENX US, INC. | $118 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-14 | ARGENX US, INC. | $49 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-14 | SK Life Science, Inc. | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-14 | ARGENX US, INC. | $12 | Travel and Lodging | Cash or cash equivalent | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-14 | ARGENX US, INC. | $11 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-09 | TG Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-30 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-30 | ARGENX US, INC. | $6 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-09-29 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-25 | Eisai Inc. | $28 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-09-25 | TG Therapeutics, Inc. | $4 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-24 | JAZZ PHARMACEUTICALS INC. | $29 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-09-23 | Eisai Inc. | $500 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-19 | TG Therapeutics, Inc. | $9 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-15 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-11 | Neurocrine BioSciences, Inc. | $16 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-09 | Biogen, Inc. | $25 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2025 | |
| 2025-09-02 | TG Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-08-27 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-08-26 | ARGENX US, INC. | $6 | Food and Beverage | In-kind items and services | VYVGART Drug, Immunology | 2025 | |
| 2025-08-26 | TG Therapeutics, Inc. | $5 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-08-25 | HARMONY BIOSCIENCES LLC | $14 | Food and Beverage | In-kind items and services | WAKIX Drug, NARCOLEPSY | 2025 | |
| 2025-08-20 | Eisai Inc. | $875 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-20 | Eisai Inc. | $282 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-20 | EMD Serono, Inc. | $69 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-08-18 | Lundbeck LLC | $31 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-08-18 | Amneal Pharmaceuticals LLC | $21 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-08-14 | Eisai Inc. | $405 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-12 | Eisai Inc. | $447 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-12 | Amgen Inc. | $27 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-11 | Eisai Inc. | $14 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-08-07 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-06 | Eisai Inc. | $1,197 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-05 | Mallinckrodt Hospital Products Inc. | $13 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-08-04 | Eisai Inc. | $2,400 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $1,200 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $678 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $382 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $120 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $5 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-08-04 | Eisai Inc. | $1 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-07-29 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-07-29 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-22 | Lundbeck LLC | $25 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-22 | TG Therapeutics, Inc. | $11 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-07-22 | ARGENX US, INC. | $6 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-07-22 | Lundbeck LLC | $2 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-11 | Eisai Inc. | $378 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-07-10 | ACADIA Pharmaceuticals Inc | $13 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-07-09 | E.R. Squibb & Sons, L.L.C. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-07-09 | E.R. Squibb & Sons, L.L.C. | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-07-08 | TG Therapeutics, Inc. | $7 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-07-07 | Otsuka America Pharmaceutical, Inc. | $3,784 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-07 | Otsuka America Pharmaceutical, Inc. | $1,087 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $123 | Travel and Lodging | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-07-03 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-07-02 | Otsuka America Pharmaceutical, Inc. | $285 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-02 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-28 | Otsuka America Pharmaceutical, Inc. | $143 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | Otsuka America Pharmaceutical, Inc. | $91 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-26 | TG Therapeutics, Inc. | $14 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-06-23 | JAZZ PHARMACEUTICALS INC. | $29 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-06-19 | Lilly USA, LLC | $24 | Food and Beverage | In-kind items and services | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-06-18 | Eisai Inc. | $25 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-06-17 | ARGENX US, INC. | $6 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-06-12 | Eisai Inc. | $633 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $42 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $25 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-11 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-10 | Eisai Inc. | $1,095 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-10 | Eisai Inc. | $912 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-10 | Eisai Inc. | $748 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-10 | Eisai Inc. | $112 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-05 | Eisai Inc. | $286 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-05 | EMD Serono, Inc. | $48 | Education | In-kind items and services | 2025 | ||
| 2025-06-05 | Biogen, Inc. | $21 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2025 | |
| 2025-06-04 | Otsuka America Pharmaceutical, Inc. | $3,784 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-04 | Otsuka America Pharmaceutical, Inc. | $2,236 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-04 | Eisai Inc. | $750 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-04 | Eisai Inc. | $250 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-03 | Eisai Inc. | $2,920 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-03 | Eisai Inc. | $912 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-03 | Eisai Inc. | $124 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-03 | Eisai Inc. | $60 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-06-02 | Amneal Pharmaceuticals LLC | $19 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-05-30 | Otsuka America Pharmaceutical, Inc. | $1,711 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-30 | Otsuka America Pharmaceutical, Inc. | $1,711 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-30 | Otsuka America Pharmaceutical, Inc. | $26 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-30 | TG Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-05-29 | Otsuka America Pharmaceutical, Inc. | $398 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-29 | Otsuka America Pharmaceutical, Inc. | $167 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-29 | Otsuka America Pharmaceutical, Inc. | $41 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-28 | Otsuka America Pharmaceutical, Inc. | $167 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-28 | Otsuka America Pharmaceutical, Inc. | $90 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-28 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-05-25 | Eisai Inc. | $1,800 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-25 | Eisai Inc. | $500 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-23 | Otsuka America Pharmaceutical, Inc. | $2,236 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-22 | Biogen, Inc. | $11 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2025 | |
| 2025-05-20 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-19 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-16 | Biogen, Inc. | $150 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, Neurology | 2025 | |
| 2025-05-09 | Otsuka America Pharmaceutical, Inc. | $435 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-05-09 | Eisai Inc. | $182 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-01 | Eisai Inc. | $2,920 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-01 | Eisai Inc. | $1,095 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-01 | Eisai Inc. | $251 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-05-01 | Eisai Inc. | $59 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-30 | Eisai Inc. | $54 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-29 | Merz Pharmaceuticals, LLC | $24 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-04-28 | TG Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-04-26 | Eisai Inc. | $232 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $3,784 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Eisai Inc. | $2,190 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-24 | Eisai Inc. | $912 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-24 | Eisai Inc. | $125 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $48 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-24 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-22 | Vanda Pharmaceuticals Inc. | $19 | Food and Beverage | In-kind items and services | PONVORY Drug, MULTIPLE SCLEROSIS | 2025 | |
| 2025-04-21 | Lundbeck LLC | $29 | Food and Beverage | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | 2025 | |
| 2025-04-19 | Otsuka America Pharmaceutical, Inc. | $2,810 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-17 | Eisai Inc. | $384 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-04-17 | TG Therapeutics, Inc. | $9 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-04-16 | Otsuka America Pharmaceutical, Inc. | $578 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-15 | Otsuka America Pharmaceutical, Inc. | $443 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-15 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-11 | Otsuka America Pharmaceutical, Inc. | $1,720 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 |
The latest 200 records of 2,602.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Herrin, IL, county Williamson County, IL, state Illinois; placed by its city name.
| Measure | Place (city or town) Herrin, IL | County Williamson County, IL | State Illinois |
|---|---|---|---|
| Population B01003 | 12,226 | 66,876 | 12,694,798 |
| Population, 2020 census P1 | 12,352 | 67,153 | 12,812,508 |
| Median age B01002 | 41.2 | 41.6 | 39.0 |
| Under 18 B01001 | 20.8% | 21.3% | 21.8% |
| 65 and over B01001 | 19.1% | 19.6% | 17.0% |
| Households B11001 | 5,559 | 28,983 | 5,036,449 |
| Foreign born B05002 | 3.4% | 2.0% | 14.7% |
| Median household income B19013 | $59,975 | $65,604 | $83,390 |
| Median family income B19113 | $75,120 | $87,344 | $106,018 |
| Per capita income B19301 | $36,228 | $37,284 | $46,406 |
| Poverty rate B17001 | 14.5% | 13.8% | 11.8% |
| Unemployment rate B23025 | 5.9% | 5.0% | 5.8% |
| Civilian labor force B23025 | 6,247 | 31,805 | 6,652,134 |
| Mean commute (minutes) B08013 | 21.9 | 23.5 | 27.8 |
| Bachelor's degree or higher B15003 | 22.8% | 26.2% | 37.8% |
| Housing units B25001 | 6,183 | 32,084 | 5,457,452 |
| Owner-occupied B25003 | 65.7% | 70.7% | 67.1% |
| Renters B25003 | 34.3% | 29.3% | 32.9% |
| Median home value B25077 | $113,300 | $156,400 | $263,300 |
| Median gross rent B25064 | $1,002 | $930 | $1,274 |
| White, not Hispanic B03002 | 85.8% | 87.9% | 58.1% |
| Black B03002 | 4.2% | 4.3% | 13.3% |
| Hispanic or Latino B03002 | 4.3% | 2.9% | 18.8% |
| Asian B03002 | 0.4% | 1.4% | 5.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.1% |
Economy now FRED unemployment 4.6% in Sep 2026 (4.5% a year earlier); per capita personal income $78,987 in 2025, up 28% in five years (+3.1% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Herrin, IL.
Comments